✦ LIBER ✦

M1776 Images of Disease: A Study in Irritable Bowel Syndrome and the Effect of Treatment

✍ Scribed by Carruthers, Helen R.; Miller, Vivien; Tarrier, Nicholas; Whorwell, Peter J.

Book ID: 123472631
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 94 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)61947-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mirtazapine in the treatment of irritabl

Mirtazapine in the treatment of irritable bowel syndrome: A pilot study

✍ L. Tanum; N. Moe 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Effectiveness of Probiotics in the Treat

Effectiveness of Probiotics in the Treatment of Irritable Bowel Syndrome

✍ Dr. Sheila M. Wilhelm; Christine M. Brubaker; Elizabeth A. Varcak; Dr. Pramodini 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

The menstrual cycle and its effect on in

The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study

✍ Sunanda V. Kane; Karen Sable; Stephen B. Hanauer 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 155 KB

Meta-analysis: the treatment of irritabl

Meta-analysis: the treatment of irritable bowel syndrome

✍ D. Lesbros-Pantoflickova; P. Michetti; M. Fried; C. Beglinger; A. L. Blum 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB

M1820 A Comparison of Disease Impacts On

M1820 A Comparison of Disease Impacts On Quality of Life Between Inflammatory Bowel Disease and Irritable Bowel Syndrome

✍ Kim, Sang Joong; Choi, Chang Hwan; Mun, Jang Sik; Moon, Hong Ju; Lee, Hyun Woong 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Duloxetine in the treatment of irritable

Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study

✍ Brian P. Brennan; Kate V. Fogarty; Jacqueline L. Roberts; Karina A. Reynolds; Ha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). ## Methods We conducted an open‐label 12‐week trial of duloxetine 60 mg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal